201 related articles for article (PubMed ID: 25560781)
1. Salivary interleukin-6 in the detection of oral cancer and precancer.
Panneer Selvam N; Sadaksharam J
Asia Pac J Clin Oncol; 2015 Sep; 11(3):236-41. PubMed ID: 25560781
[TBL] [Abstract][Full Text] [Related]
2. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
3. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma.
Punyani SR; Sathawane RS
Clin Oral Investig; 2013 Mar; 17(2):517-24. PubMed ID: 22526890
[TBL] [Abstract][Full Text] [Related]
4. Salivary mRNA markers having the potential to detect oral squamous cell carcinoma segregated from oral leukoplakia with dysplasia.
Michailidou E; Tzimagiorgis G; Chatzopoulou F; Vahtsevanos K; Antoniadis K; Kouidou S; Markopoulos A; Antoniades D
Cancer Epidemiol; 2016 Aug; 43():112-8. PubMed ID: 27263493
[TBL] [Abstract][Full Text] [Related]
5. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
6. Salivary and Serum Interleukin-6: A Credible Marker for Predicting Oral Leukoplakia and Oral Squamous Cell Carcinoma by Enzyme-Linked Immunosorbent Assay (ELISA).
Oshin M; Kulkarni PG; D SPR; Deepthi G; S KS; S JK
Cureus; 2024 Apr; 16(4):e59113. PubMed ID: 38803729
[TBL] [Abstract][Full Text] [Related]
7. Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia.
Bagan L; Sáez GT; Tormos MC; Labaig-Rueda C; Murillo-Cortes J; Bagan JV
Clin Oral Investig; 2016 May; 20(4):737-43. PubMed ID: 26254143
[TBL] [Abstract][Full Text] [Related]
8. Detection of interleukins-6 and 8 in saliva as potential biomarkers of oral pre-malignant lesion and oral carcinoma: A breakthrough in salivary diagnostics in Pakistan.
Khyani IAM; Qureshi MA; Mirza T; Farooq MU
Pak J Pharm Sci; 2017 May; 30(3):817-823. PubMed ID: 28653927
[TBL] [Abstract][Full Text] [Related]
9. Salivary interleukin-6 and -8 in patients with oral cancer and patients with chronic oral inflammatory diseases.
Lisa Cheng YS; Jordan L; Gorugantula LM; Schneiderman E; Chen HS; Rees T
J Periodontol; 2014 Jul; 85(7):956-65. PubMed ID: 24147842
[TBL] [Abstract][Full Text] [Related]
10. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.
Csősz É; Lábiscsák P; Kalló G; Márkus B; Emri M; Szabó A; Tar I; Tőzsér J; Kiss C; Márton I
PLoS One; 2017; 12(5):e0177282. PubMed ID: 28545132
[TBL] [Abstract][Full Text] [Related]
11. Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma.
Ko HH; Peng HH; Cheng SJ; Kuo MY
Head Neck; 2018 Dec; 40(12):2642-2647. PubMed ID: 30430672
[TBL] [Abstract][Full Text] [Related]
12. Salivary metabolite signatures of oral cancer and leukoplakia.
Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
[TBL] [Abstract][Full Text] [Related]
13. Analysis of tumor marker CA 125 in saliva of normal and oral squamous cell carcinoma patients: a comparative study.
Balan JJ; Rao RS; Premalatha BR; Patil S
J Contemp Dent Pract; 2012 Sep; 13(5):671-5. PubMed ID: 23250173
[TBL] [Abstract][Full Text] [Related]
14. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
16. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
Aziz S; Ahmed SS; Ali A; Khan FA; Zulfiqar G; Iqbal J; Khan AA; Shoaib M
Cancer Invest; 2015; 33(7):318-28. PubMed ID: 26046681
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
18. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
[TBL] [Abstract][Full Text] [Related]
19. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity.
Rajkumar K; Nandhini G; Ramya R; Rajashree P; Kumar AR; Anandan SN
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Sep; 118(3):309-19. PubMed ID: 24950604
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
Lin L; Wang J; Liu D; Liu S; Xu H; Ji N; Zhou M; Zeng X; Zhang D; Li J; Chen Q
Sci Rep; 2016 May; 6():26757. PubMed ID: 27225603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
